Cargando…

A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells

PURPOSE: Nanomedicine has emerged as a novel therapeutic modality for cancer treatment and diagnosis. Lipid–polymer hybrid nanoparticles (LPHNPs) are core–shell nanoparticle (NP) structures comprising polymer cores and lipid shells, which exhibit complementary characteristics of both polymeric NPs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chunyan, Sun, Jiangchuan, Chen, Shuning, Liu, Yujiao, Zhu, Shenyin, Wang, Zhigang, Chang, Shufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345190/
https://www.ncbi.nlm.nih.gov/pubmed/30718954
http://dx.doi.org/10.2147/IJN.S187929
_version_ 1783389542240223232
author Chen, Chunyan
Sun, Jiangchuan
Chen, Shuning
Liu, Yujiao
Zhu, Shenyin
Wang, Zhigang
Chang, Shufang
author_facet Chen, Chunyan
Sun, Jiangchuan
Chen, Shuning
Liu, Yujiao
Zhu, Shenyin
Wang, Zhigang
Chang, Shufang
author_sort Chen, Chunyan
collection PubMed
description PURPOSE: Nanomedicine has emerged as a novel therapeutic modality for cancer treatment and diagnosis. Lipid–polymer hybrid nanoparticles (LPHNPs) are core–shell nanoparticle (NP) structures comprising polymer cores and lipid shells, which exhibit complementary characteristics of both polymeric NPs and liposomes. However, it is difficult to wrap perfluoropentane (PFP) into core–shell NPs in the existing preparation process, which limits its application in the integration of diagnosis and treatment. METHODS: The folate-targeted LPHNPs-loaded indocyanine green/PFP-carrying oxygen (TOI_HNPs) using a combination of two-step method and solution evaporation technique for the first time. The essential properties and dual-mode imaging characteristics of developed NPs were determined. The cellular uptake of TOI_HNPs was detected by confocal microscopy and flow cytometry. The SKOV3 cell viability and apoptosis rate were evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and flow cytometry. The ROS was demonstrated by fluorescence microplate reader and the expression of hypoxia-inducible factor 1-alpha (HIF-1α) and IL-6 was detected by Western blot. RESULTS: TOI_HNPs showed spherical morphology with particle size about (166.83±5.54) nm and zeta potential at −(30.57±1.36) mV. It exhibited better stability than lipid NPs and higher encapsulation efficiency as well as active targeting ability than poly (lactic-co-glycolic acid) (PLGA) NPs. In addition, the novel NPs could also act as the contrast agents for ultrasound and photoacoustic imaging, providing precision guidance and monitoring. Furthermore, TOI_HNPs-mediated photo–sonodynamic therapy (PSDT) caused more serious cell damage and more obvious cell apoptosis, compared with other groups. The PSDT mediated by TOI_HNPs induced generation of intracellular ROS and downregulated the expression of HIF-1α and IL-6 in SKOV3 cells. CONCLUSION: This kind of multifunctional-targeted nanoagent may provide an ideal strategy for combination of high therapeutic efficacy and dual-mode imaging guidance.
format Online
Article
Text
id pubmed-6345190
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63451902019-02-04 A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells Chen, Chunyan Sun, Jiangchuan Chen, Shuning Liu, Yujiao Zhu, Shenyin Wang, Zhigang Chang, Shufang Int J Nanomedicine Original Research PURPOSE: Nanomedicine has emerged as a novel therapeutic modality for cancer treatment and diagnosis. Lipid–polymer hybrid nanoparticles (LPHNPs) are core–shell nanoparticle (NP) structures comprising polymer cores and lipid shells, which exhibit complementary characteristics of both polymeric NPs and liposomes. However, it is difficult to wrap perfluoropentane (PFP) into core–shell NPs in the existing preparation process, which limits its application in the integration of diagnosis and treatment. METHODS: The folate-targeted LPHNPs-loaded indocyanine green/PFP-carrying oxygen (TOI_HNPs) using a combination of two-step method and solution evaporation technique for the first time. The essential properties and dual-mode imaging characteristics of developed NPs were determined. The cellular uptake of TOI_HNPs was detected by confocal microscopy and flow cytometry. The SKOV3 cell viability and apoptosis rate were evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and flow cytometry. The ROS was demonstrated by fluorescence microplate reader and the expression of hypoxia-inducible factor 1-alpha (HIF-1α) and IL-6 was detected by Western blot. RESULTS: TOI_HNPs showed spherical morphology with particle size about (166.83±5.54) nm and zeta potential at −(30.57±1.36) mV. It exhibited better stability than lipid NPs and higher encapsulation efficiency as well as active targeting ability than poly (lactic-co-glycolic acid) (PLGA) NPs. In addition, the novel NPs could also act as the contrast agents for ultrasound and photoacoustic imaging, providing precision guidance and monitoring. Furthermore, TOI_HNPs-mediated photo–sonodynamic therapy (PSDT) caused more serious cell damage and more obvious cell apoptosis, compared with other groups. The PSDT mediated by TOI_HNPs induced generation of intracellular ROS and downregulated the expression of HIF-1α and IL-6 in SKOV3 cells. CONCLUSION: This kind of multifunctional-targeted nanoagent may provide an ideal strategy for combination of high therapeutic efficacy and dual-mode imaging guidance. Dove Medical Press 2019-01-21 /pmc/articles/PMC6345190/ /pubmed/30718954 http://dx.doi.org/10.2147/IJN.S187929 Text en © 2019 Chen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Chen, Chunyan
Sun, Jiangchuan
Chen, Shuning
Liu, Yujiao
Zhu, Shenyin
Wang, Zhigang
Chang, Shufang
A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title_full A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title_fullStr A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title_full_unstemmed A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title_short A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
title_sort multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345190/
https://www.ncbi.nlm.nih.gov/pubmed/30718954
http://dx.doi.org/10.2147/IJN.S187929
work_keys_str_mv AT chenchunyan amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT sunjiangchuan amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT chenshuning amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT liuyujiao amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT zhushenyin amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT wangzhigang amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT changshufang amultifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT chenchunyan multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT sunjiangchuan multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT chenshuning multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT liuyujiao multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT zhushenyin multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT wangzhigang multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells
AT changshufang multifunctionaltargetednanoagentfordualmodeimageguidedtherapeuticeffectsonovariancancercells